Sobre nosotros

Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases.

Sector
Investigación biotecnológica
Tamaño de la empresa
De 51 a 200 empleados
Sede
Antwerp
Tipo
De financiación privada
Fundación
2017

Ubicaciones

Empleados en Agomab

Actualizaciones

Páginas similares

Buscar empleos